Task: Answer the multiple-choice question.
Query: Which drug exhibits a -19.777% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) Cc1csc(NC(=O)C2CCCN2C(=O)Oc2ccccc2)n1
(b) CCOc1ccc(-c2nc(-c3ccccc3C)no2)cc1
(c) O=C(CC(SCCO)c1ccc2c(c1)OCO2)c1ccco1
(d) COc1ccc(CCNC(=O)/C=C\c2ccccc2)cc1OC
Answer: a. Cc1csc(NC(=O)C2CCCN2C(=O)Oc2ccccc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1csc(NC(=O)C2CCCN2C(=O)Oc2ccccc2)n1
Cc1csc(NC(=O)C2CCCN2C(=O)Oc2ccccc2)n1
phenyl 2-[(4-methyl-1,3-thiazol-2-yl)carbamoyl]pyrrolidine-1-carboxylate